Durvalumab vs Finasteride

## Durvalumab vs Finasteride: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Finasteride**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Finasteride**: Competitive inhibitor of 5-alpha-reductase type II.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Finasteride — 5-6 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Finasteride — C23H36N2O2.

**Molecular Weight**: Durvalumab — N/A; Finasteride — 372.5490 g/mol.

**Type**: Durvalumab — Antibody; Finasteride — Small molecule.